TWI369991B - Use of clostridium perfringens type c bacterium for the manufacture of a vaccine - Google Patents

Use of clostridium perfringens type c bacterium for the manufacture of a vaccine

Info

Publication number
TWI369991B
TWI369991B TW096140460A TW96140460A TWI369991B TW I369991 B TWI369991 B TW I369991B TW 096140460 A TW096140460 A TW 096140460A TW 96140460 A TW96140460 A TW 96140460A TW I369991 B TWI369991 B TW I369991B
Authority
TW
Taiwan
Prior art keywords
vaccine
bacterium
clostridium perfringens
manufacture
perfringens type
Prior art date
Application number
TW096140460A
Other languages
English (en)
Chinese (zh)
Other versions
TW200831121A (en
Inventor
Maarten Hendrik Witvliet
Jozef Franciscus Maria Smeets
Keith Redhead
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of TW200831121A publication Critical patent/TW200831121A/zh
Application granted granted Critical
Publication of TWI369991B publication Critical patent/TWI369991B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
TW096140460A 2006-11-20 2007-10-26 Use of clostridium perfringens type c bacterium for the manufacture of a vaccine TWI369991B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86044706P 2006-11-20 2006-11-20
EP06124404 2006-11-20

Publications (2)

Publication Number Publication Date
TW200831121A TW200831121A (en) 2008-08-01
TWI369991B true TWI369991B (en) 2012-08-11

Family

ID=38535530

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096140460A TWI369991B (en) 2006-11-20 2007-10-26 Use of clostridium perfringens type c bacterium for the manufacture of a vaccine

Country Status (8)

Country Link
CN (1) CN101541343B (pt)
AT (1) ATE540692T1 (pt)
BR (1) BRPI0718639A2 (pt)
DK (1) DK2086578T3 (pt)
ES (1) ES2380134T3 (pt)
RU (1) RU2462263C2 (pt)
TW (1) TWI369991B (pt)
UA (1) UA95652C2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102688484B (zh) * 2012-06-13 2016-03-30 北京中海生物科技有限公司 一种鸡坏死性肠炎（c型）灭活疫苗的生产方法
CN107789622A (zh) * 2017-10-18 2018-03-13 山东农业大学 一种犊牛肠毒血症产气荚膜梭菌β2毒素类毒素疫苗的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2129441C1 (ru) * 1997-12-10 1999-04-27 Пирожков Михаил Константинович Вакцина, ассоциированная против анаэробной энтеротоксемии и эшерихиоза поросят

Also Published As

Publication number Publication date
TW200831121A (en) 2008-08-01
CN101541343A (zh) 2009-09-23
BRPI0718639A2 (pt) 2013-11-26
RU2009123478A (ru) 2010-12-27
ATE540692T1 (de) 2012-01-15
ES2380134T3 (es) 2012-05-08
RU2462263C2 (ru) 2012-09-27
CN101541343B (zh) 2012-05-16
UA95652C2 (ru) 2011-08-25
DK2086578T3 (da) 2012-05-14

Similar Documents

Publication Publication Date Title
BR112012014082A2 (pt) composições e métodos que compreendem variantes de protease
MX2012007098A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
IN2012DN00829A (pt)
MX2012007161A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
MY153915A (en) Organic compounds
UA106748C2 (uk) Похідні проліну як інгібітори катепсину
PH12012501346A1 (en) Heteroaryl compounds and uses thereof
MX2012004780A (es) Inhibidores de akt.
IL186701A0 (en) C. perfringens alpha toxoid vaccine
CA2798214C (en) Vaccine against beta-herpesvirus infection and use thereof
BRPI1015043A2 (pt) derivados de diazahomoadamantano e métodos de uso dos mesmos
MX2009005938A (es) 6-oxo-1,6-dihidro-pirimidin-2-ilos en el tratamiento de enfermedades proliferativas.
MX2010005004A (es) Composiciones y dispositivos.
MX2010004487A (es) Derivados lactamicos sustituidos y sus usos para glaucoma e hipertension ocular.
AU2010280497A8 (en) Anhydrate of tiotropium bromide
MX2009001578A (es) Lactamas terapeuticas.
MX2009005117A (es) Uso de bacteria clostridium perfringens de tipo c para la elaboracion de una vacuna.
UA95652C2 (ru) Применение бактерии clostridium perfringens типа c для производства вакцины для защиты свиней от инфекции clostridium perfringens типа а
MX349563B (es) Formulacion farmaceutica de fenofibrato nanonizado.
MX2009007929A (es) Uso de un primer alergeno del grupo 2 de acaro de polvo de casa para tratar alergia a un segundo alergeno del grupo 2 de acaro de polvo de casa.
ATE551036T1 (de) Kondomverpackung
MX2012007097A (es) Derivados fenolicos y su uso farmaceutico o cosmetico.
IL197769A0 (en) Novel morphine derivatives
TNSN08242A1 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MY158116A (en) Combination vaccine against streptococcus

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees